Thorax · 2025
Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline.
СтатьяМногоцентровое исследованиеПоддержка NIH: внешняя программаНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pottinger Tess, Liu Zhonghua, Liu Lili, Buschur Kristina L, Curtis Jeffrey L, Manichaikul Ani, Rich Stephen S, Ortega Victor E, Bleecker Eugene R, Meyers Deborah A, Hoffman Eric A, Smith Benjamin, Novak Jan, Kiryluk Krzysztof, Barr R Graham
Аннотация
RATIONALE: Immunoglobulin A (IgA) deficiency, a rare, highly heritable trait, is associated with frequent pulmonary infections, emphysema, airway changes and low lung function; however, it is unclear if reduced IgA levels may affect lung structure and function.
METHODS: Serum IgA, IgA1 and galactose-deficient IgA1 (Gd-IgA1) levels were measured in the population-based Multi-Ethnic Study on Atherosclerosis (MESA). The MESA Lung Study measured percent emphysema on cardiac CT and airway dimensions on chest CT, and performed spirometry. Regression models were evaluated after adjustment for demographic and CT factors. Mendelian randomisation (MR) analyses were conducted using genetic variants from the Trans-Omics for Precision Medicine (TOPMed) programme. A replication analysis was performed in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS).
MEASUREMENTS AND MAIN RESULTS: Among 5497 participants, lower log-normalised serum IgA levels were associated with greater percent emphysema (β=-0.084; 95% CI -0.14 to -0.026; p=0.005), which was confirmed on MR (β=-0.79; 95% CI -1.4 to -0.18; p=0.011). Greater log-normalised serum Gd-IgA1 levels were associated with airway wall thickness (β=0.0079; 95% CI 0.0017 to 0.014; p=0.012; n=2580) and decline in the forced expiratory volume in one second (FEV1) (β=-0.012; 95% CI -0.021 to -0.0036; p=0.0055; n=2778) and FEV1/forced vital capacity (FVC) ratio (β=-0.0028; 95% CI -0.0048 to -0.00084; p=0.0054; n=2778).
CONCLUSION: Lower serum IgA levels were associated with greater percent emphysema. Additionally, higher Gd-IgA1 levels were associated with airway wall thickness and lung function decline. These findings support a protective role of IgA in emphysema pathogenesis and possible deleterious role of Gd-IgA1 in airway diseases.
METHODS: Serum IgA, IgA1 and galactose-deficient IgA1 (Gd-IgA1) levels were measured in the population-based Multi-Ethnic Study on Atherosclerosis (MESA). The MESA Lung Study measured percent emphysema on cardiac CT and airway dimensions on chest CT, and performed spirometry. Regression models were evaluated after adjustment for demographic and CT factors. Mendelian randomisation (MR) analyses were conducted using genetic variants from the Trans-Omics for Precision Medicine (TOPMed) programme. A replication analysis was performed in the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS).
MEASUREMENTS AND MAIN RESULTS: Among 5497 participants, lower log-normalised serum IgA levels were associated with greater percent emphysema (β=-0.084; 95% CI -0.14 to -0.026; p=0.005), which was confirmed on MR (β=-0.79; 95% CI -1.4 to -0.18; p=0.011). Greater log-normalised serum Gd-IgA1 levels were associated with airway wall thickness (β=0.0079; 95% CI 0.0017 to 0.014; p=0.012; n=2580) and decline in the forced expiratory volume in one second (FEV1) (β=-0.012; 95% CI -0.021 to -0.0036; p=0.0055; n=2778) and FEV1/forced vital capacity (FVC) ratio (β=-0.0028; 95% CI -0.0048 to -0.00084; p=0.0054; n=2778).
CONCLUSION: Lower serum IgA levels were associated with greater percent emphysema. Additionally, higher Gd-IgA1 levels were associated with airway wall thickness and lung function decline. These findings support a protective role of IgA in emphysema pathogenesis and possible deleterious role of Gd-IgA1 in airway diseases.